ClinicalTrials.gg
Sign In

Muscle Weakness clinical trials

The registry lists 477 studies for Muscle Weakness across more than 10 countries. 73 are recruiting or about to start. 244 of them are mainly about Muscle Weakness (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Muscle Weakness studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
301
Status unknown
56
Recruiting
54
Terminated
22
Active, not recruiting
17
Not yet recruiting
15

Phase

Phase 2
26
Phase 4
20
Phase 3
12
Phase 1
12
Early Phase 1
2

Where

United States
145
Turkey
44
France
28
Spain
27
Germany
24
Brazil
23

Who runs them

Riphah International University (9) · Hacettepe University (8) · Cairo University (7) · Charite University, Berlin, Germany (5) · University of Saskatchewan (5) · University of Chile (5) · Bezmialem Vakif University (4) · Centre Hospitalier Universitaire de Saint Etienne (4)

What is being tested here

Drugs under test in Muscle Weakness studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Vitamin D105
Methylprednisolone103
Creatine113
Metformin101
Anitocabtagene autoleucel101
Dexamethasone101
Napazimone101
Methylprednisolone Acetate101
Testosterone014
Beta-hydroxyisovaleric acid003

Drug classes tested here Corticosteroids 2 open · Androgens 6

Coming up

0phase 3 studies under way
23studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 54 Muscle Weakness studies recruiting now, 24 (44%) set no upper age limit and 22 (41%) stop at 75 or younger. 6 (11%) take children under 18. 4 (7%) are for women only and 1 (2%) for men only; 19 (35%) take healthy volunteers.

Recruiting studies that take each age, of 54
AgeWomenMen
106 (11%)6 (11%)
1833 (61%)31 (57%)
3035 (65%)33 (61%)
4042 (78%)39 (72%)
5041 (76%)38 (70%)
6541 (76%)39 (72%)
7534 (63%)34 (63%)
8529 (54%)30 (56%)

Across all 477 studies, recruiting or not: 44% stop at 75 or younger and 34% at 65; 11% take children; 9% are for women only and 5% for men only; 37% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Muscle Weakness studies take

Of 212 interventional studies with no phase under Muscle Weakness, half reached primary completion within 12 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase12 mo5–28 · 212 studies—12 mo5–28 · 200 studies
Observational26 mo12–63 · 50 studies—25 mo12–63 · 48 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 477. Browse all 477 → or search them.